REGULATORY INTELLIGENCE·Recall
Pfizer's Bicillin L-A Class II Recall: CGMP Deviations and Particulates Trigger Nationwide Supply Chain Disruption
Pfizer Laboratories Div Pfizer Inc. has initiated a Class II recall for 50,855 vials of Bicillin L-A (penicillin G benzathine injectable suspension) across the U.S. This voluntary action stems from critical CGMP deviations and the presence of particulate matter identified during visual inspection. This event signals significant supply chain risks and mandates immediate review of quality assurance protocols for sterile injectables.
90-Day Activity